{"entity":{"type":"insider","cik":"0001517691","url":"/insider/0001517691","json_url":"/insider/0001517691.json","name":"Niihara Yutaka","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":374,"n_filings":132,"first":"2013-06-04","last":"2022-12-01","span_basis":"filed_date"},"name_variants":[{"name":"Niihara Yutaka","source":"filing","n_filings":132,"first_seen":"2013-06-04","last_seen":"2022-12-01"}],"transactions":[{"id":6518624,"accession":"0001209191-22-059154","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-22-059154","line_url":"/filing/0001209191-22-059154#line-5","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517691","owner_name":"Niihara Yutaka","owner_display_name":"Niihara Yutaka","owner_url":"/insider/0001517691","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":22900.0,"shares_display":"22,900","price_per_share":0.41,"price_display":"0.41","price_state":"stated","total_value":9389.0,"total_display":"9,389.00","total_whole":"9,389","shares_owned_after":12040857.0,"shares_owned_after_display":"12,040,857","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-30","filed_date":"2022-12-01","scope":"insider"},{"id":6518619,"accession":"0001209191-22-059154","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-22-059154","line_url":"/filing/0001209191-22-059154#line-4","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517691","owner_name":"Niihara Yutaka","owner_display_name":"Niihara Yutaka","owner_url":"/insider/0001517691","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":14700.0,"shares_display":"14,700","price_per_share":0.38,"price_display":"0.38","price_state":"stated","total_value":5586.0,"total_display":"5,586.00","total_whole":"5,586","shares_owned_after":12017957.0,"shares_owned_after_display":"12,017,957","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-29","filed_date":"2022-12-01","scope":"insider"},{"id":6518617,"accession":"0001209191-22-059154","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-059154","line_url":"/filing/0001209191-22-059154#line-3","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517691","owner_name":"Niihara Yutaka","owner_display_name":"Niihara Yutaka","owner_url":"/insider/0001517691","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.35,"price_display":"0.35","price_state":"stated","total_value":1750.0,"total_display":"1,750.00","total_whole":"1,750","shares_owned_after":12003257.0,"shares_owned_after_display":"12,003,257","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-28","filed_date":"2022-12-01","scope":"insider"},{"id":6518612,"accession":"0001209191-22-059154","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-059154","line_url":"/filing/0001209191-22-059154#line-2","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517691","owner_name":"Niihara Yutaka","owner_display_name":"Niihara Yutaka","owner_url":"/insider/0001517691","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7500.0,"shares_display":"7,500","price_per_share":0.45,"price_display":"0.45","price_state":"stated","total_value":3375.0,"total_display":"3,375.00","total_whole":"3,375","shares_owned_after":11998257.0,"shares_owned_after_display":"11,998,257","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-04","filed_date":"2022-12-01","scope":"insider"},{"id":6518608,"accession":"0001209191-22-059154","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-059154","line_url":"/filing/0001209191-22-059154#line-1","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517691","owner_name":"Niihara Yutaka","owner_display_name":"Niihara Yutaka","owner_url":"/insider/0001517691","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":0.45,"price_display":"0.45","price_state":"stated","total_value":1125.0,"total_display":"1,125.00","total_whole":"1,125","shares_owned_after":11990757.0,"shares_owned_after_display":"11,990,757","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-03","filed_date":"2022-12-01","scope":"insider"},{"id":6253163,"accession":"0001209191-22-055471","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-055471","line_url":"/filing/0001209191-22-055471#line-3","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517691","owner_name":"Niihara Yutaka","owner_display_name":"Niihara Yutaka","owner_url":"/insider/0001517691","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":0.43,"price_display":"0.43","price_state":"stated","total_value":6450.0,"total_display":"6,450.00","total_whole":"6,450","shares_owned_after":11988257.0,"shares_owned_after_display":"11,988,257","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-02","filed_date":"2022-11-03","scope":"insider"},{"id":6253160,"accession":"0001209191-22-055471","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-055471","line_url":"/filing/0001209191-22-055471#line-2","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517691","owner_name":"Niihara Yutaka","owner_display_name":"Niihara Yutaka","owner_url":"/insider/0001517691","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.43,"price_display":"0.43","price_state":"stated","total_value":2150.0,"total_display":"2,150.00","total_whole":"2,150","shares_owned_after":11973257.0,"shares_owned_after_display":"11,973,257","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-01","filed_date":"2022-11-03","scope":"insider"},{"id":6253157,"accession":"0001209191-22-055471","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-055471","line_url":"/filing/0001209191-22-055471#line-1","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517691","owner_name":"Niihara Yutaka","owner_display_name":"Niihara Yutaka","owner_url":"/insider/0001517691","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7500.0,"shares_display":"7,500","price_per_share":0.45,"price_display":"0.45","price_state":"stated","total_value":3375.0,"total_display":"3,375.00","total_whole":"3,375","shares_owned_after":11968257.0,"shares_owned_after_display":"11,968,257","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-31","filed_date":"2022-11-03","scope":"insider"},{"id":6926794,"accession":"0001209191-22-054902","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-22-054902","line_url":"/filing/0001209191-22-054902#line-5","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517691","owner_name":"Niihara Yutaka","owner_display_name":"Niihara Yutaka","owner_url":"/insider/0001517691","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7500.0,"shares_display":"7,500","price_per_share":0.42,"price_display":"0.42","price_state":"stated","total_value":3150.0,"total_display":"3,150.00","total_whole":"3,150","shares_owned_after":11960757.0,"shares_owned_after_display":"11,960,757","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-28","filed_date":"2022-10-31","scope":"insider"},{"id":6926790,"accession":"0001209191-22-054902","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-22-054902","line_url":"/filing/0001209191-22-054902#line-4","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517691","owner_name":"Niihara Yutaka","owner_display_name":"Niihara Yutaka","owner_url":"/insider/0001517691","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":22500.0,"shares_display":"22,500","price_per_share":0.27,"price_display":"0.27","price_state":"stated","total_value":6075.0,"total_display":"6,075.00","total_whole":"6,075","shares_owned_after":11953257.0,"shares_owned_after_display":"11,953,257","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-27","filed_date":"2022-10-31","scope":"insider"},{"id":6926787,"accession":"0001209191-22-054902","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-054902","line_url":"/filing/0001209191-22-054902#line-3","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517691","owner_name":"Niihara Yutaka","owner_display_name":"Niihara Yutaka","owner_url":"/insider/0001517691","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11900.0,"shares_display":"11,900","price_per_share":0.27,"price_display":"0.27","price_state":"stated","total_value":3213.0,"total_display":"3,213.00","total_whole":"3,213","shares_owned_after":11930757.0,"shares_owned_after_display":"11,930,757","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-26","filed_date":"2022-10-31","scope":"insider"},{"id":6926784,"accession":"0001209191-22-054902","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-054902","line_url":"/filing/0001209191-22-054902#line-2","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517691","owner_name":"Niihara Yutaka","owner_display_name":"Niihara Yutaka","owner_url":"/insider/0001517691","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.26,"price_display":"0.26","price_state":"stated","total_value":5200.0,"total_display":"5,200.00","total_whole":"5,200","shares_owned_after":11918857.0,"shares_owned_after_display":"11,918,857","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-25","filed_date":"2022-10-31","scope":"insider"},{"id":6926781,"accession":"0001209191-22-054902","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-054902","line_url":"/filing/0001209191-22-054902#line-1","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517691","owner_name":"Niihara Yutaka","owner_display_name":"Niihara Yutaka","owner_url":"/insider/0001517691","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7500.0,"shares_display":"7,500","price_per_share":0.22,"price_display":"0.22","price_state":"stated","total_value":1650.0,"total_display":"1,650.00","total_whole":"1,650","shares_owned_after":11898857.0,"shares_owned_after_display":"11,898,857","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-24","filed_date":"2022-10-31","scope":"insider"},{"id":6431823,"accession":"0001209191-22-054449","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-054449","line_url":"/filing/0001209191-22-054449#line-3","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517691","owner_name":"Niihara Yutaka","owner_display_name":"Niihara Yutaka","owner_url":"/insider/0001517691","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.19,"price_display":"0.19","price_state":"stated","total_value":1900.0,"total_display":"1,900.00","total_whole":"1,900","shares_owned_after":11891357.0,"shares_owned_after_display":"11,891,357","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-21","filed_date":"2022-10-24","scope":"insider"},{"id":6431820,"accession":"0001209191-22-054449","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-054449","line_url":"/filing/0001209191-22-054449#line-2","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517691","owner_name":"Niihara Yutaka","owner_display_name":"Niihara Yutaka","owner_url":"/insider/0001517691","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":0.18,"price_display":"0.18","price_state":"stated","total_value":5400.0,"total_display":"5,400.00","total_whole":"5,400","shares_owned_after":11881357.0,"shares_owned_after_display":"11,881,357","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-20","filed_date":"2022-10-24","scope":"insider"},{"id":6431817,"accession":"0001209191-22-054449","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-054449","line_url":"/filing/0001209191-22-054449#line-1","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517691","owner_name":"Niihara Yutaka","owner_display_name":"Niihara Yutaka","owner_url":"/insider/0001517691","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":0.16,"price_display":"0.16","price_state":"stated","total_value":4000.0,"total_display":"4,000.00","total_whole":"4,000","shares_owned_after":11851357.0,"shares_owned_after_display":"11,851,357","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-19","filed_date":"2022-10-24","scope":"insider"},{"id":6613716,"accession":"0001209191-22-054051","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-054051","line_url":"/filing/0001209191-22-054051#line-2","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517691","owner_name":"Niihara Yutaka","owner_display_name":"Niihara Yutaka","owner_url":"/insider/0001517691","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":0.19,"price_display":"0.19","price_state":"stated","total_value":5700.0,"total_display":"5,700.00","total_whole":"5,700","shares_owned_after":11826357.0,"shares_owned_after_display":"11,826,357","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-18","filed_date":"2022-10-19","scope":"insider"},{"id":6613711,"accession":"0001209191-22-054051","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-054051","line_url":"/filing/0001209191-22-054051#line-1","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517691","owner_name":"Niihara Yutaka","owner_display_name":"Niihara Yutaka","owner_url":"/insider/0001517691","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":0.2,"price_display":"0.20","price_state":"stated","total_value":3000.0,"total_display":"3,000.00","total_whole":"3,000","shares_owned_after":11796357.0,"shares_owned_after_display":"11,796,357","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-17","filed_date":"2022-10-19","scope":"insider"},{"id":6673370,"accession":"0001209191-22-053757","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-053757","line_url":"/filing/0001209191-22-053757#line-2","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517691","owner_name":"Niihara Yutaka","owner_display_name":"Niihara Yutaka","owner_url":"/insider/0001517691","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":35000.0,"shares_display":"35,000","price_per_share":0.17,"price_display":"0.17","price_state":"stated","total_value":5950.0,"total_display":"5,950.00","total_whole":"5,950","shares_owned_after":11781357.0,"shares_owned_after_display":"11,781,357","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-14","filed_date":"2022-10-17","scope":"insider"},{"id":6673365,"accession":"0001209191-22-053757","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-053757","line_url":"/filing/0001209191-22-053757#line-1","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517691","owner_name":"Niihara Yutaka","owner_display_name":"Niihara Yutaka","owner_url":"/insider/0001517691","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":62500.0,"shares_display":"62,500","price_per_share":0.18,"price_display":"0.18","price_state":"stated","total_value":11250.0,"total_display":"11,250.00","total_whole":"11,250","shares_owned_after":11746357.0,"shares_owned_after_display":"11,746,357","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-13","filed_date":"2022-10-17","scope":"insider"},{"id":6673337,"accession":"0001209191-22-053559","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-053559","line_url":"/filing/0001209191-22-053559#line-2","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517691","owner_name":"Niihara Yutaka","owner_display_name":"Niihara Yutaka","owner_url":"/insider/0001517691","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":160000.0,"shares_display":"160,000","price_per_share":0.08,"price_display":"0.08","price_state":"stated","total_value":12800.0,"total_display":"12,800.00","total_whole":"12,800","shares_owned_after":11683857.0,"shares_owned_after_display":"11,683,857","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-12","filed_date":"2022-10-13","scope":"insider"},{"id":6673332,"accession":"0001209191-22-053559","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-053559","line_url":"/filing/0001209191-22-053559#line-1","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517691","owner_name":"Niihara Yutaka","owner_display_name":"Niihara Yutaka","owner_url":"/insider/0001517691","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.09,"price_display":"0.09","price_state":"stated","total_value":450.0,"total_display":"450.00","total_whole":"450","shares_owned_after":11523857.0,"shares_owned_after_display":"11,523,857","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-11","filed_date":"2022-10-13","scope":"insider"},{"id":6107051,"accession":"0001209191-22-053433","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-22-053433","line_url":"/filing/0001209191-22-053433#line-9","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517691","owner_name":"Niihara Yutaka","owner_display_name":"Niihara Yutaka","owner_url":"/insider/0001517691","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":130000.0,"shares_display":"130,000","price_per_share":0.09,"price_display":"0.09","price_state":"stated","total_value":11700.0,"total_display":"11,700.00","total_whole":"11,700","shares_owned_after":11518857.0,"shares_owned_after_display":"11,518,857","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-11","filed_date":"2022-10-12","scope":"insider"},{"id":6107048,"accession":"0001209191-22-053433","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-22-053433","line_url":"/filing/0001209191-22-053433#line-8","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517691","owner_name":"Niihara Yutaka","owner_display_name":"Niihara Yutaka","owner_url":"/insider/0001517691","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.09,"price_display":"0.09","price_state":"stated","total_value":900.0,"total_display":"900.00","total_whole":"900","shares_owned_after":11388857.0,"shares_owned_after_display":"11,388,857","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-10","filed_date":"2022-10-12","scope":"insider"},{"id":6107046,"accession":"0001209191-22-053433","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-22-053433","line_url":"/filing/0001209191-22-053433#line-7","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517691","owner_name":"Niihara Yutaka","owner_display_name":"Niihara Yutaka","owner_url":"/insider/0001517691","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":0.13,"price_display":"0.13","price_state":"stated","total_value":520.0,"total_display":"520.00","total_whole":"520","shares_owned_after":11378857.0,"shares_owned_after_display":"11,378,857","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-07","filed_date":"2022-10-12","scope":"insider"},{"id":6107044,"accession":"0001209191-22-053433","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-22-053433","line_url":"/filing/0001209191-22-053433#line-6","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517691","owner_name":"Niihara Yutaka","owner_display_name":"Niihara Yutaka","owner_url":"/insider/0001517691","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.15,"price_display":"0.15","price_state":"stated","total_value":750.0,"total_display":"750.00","total_whole":"750","shares_owned_after":11374857.0,"shares_owned_after_display":"11,374,857","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-06","filed_date":"2022-10-12","scope":"insider"},{"id":6107041,"accession":"0001209191-22-053433","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-22-053433","line_url":"/filing/0001209191-22-053433#line-5","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517691","owner_name":"Niihara Yutaka","owner_display_name":"Niihara Yutaka","owner_url":"/insider/0001517691","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.15,"price_display":"0.15","price_state":"stated","total_value":1500.0,"total_display":"1,500.00","total_whole":"1,500","shares_owned_after":11369857.0,"shares_owned_after_display":"11,369,857","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-05","filed_date":"2022-10-12","scope":"insider"},{"id":6107038,"accession":"0001209191-22-053433","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-22-053433","line_url":"/filing/0001209191-22-053433#line-4","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517691","owner_name":"Niihara Yutaka","owner_display_name":"Niihara Yutaka","owner_url":"/insider/0001517691","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.16,"price_display":"0.16","price_state":"stated","total_value":800.0,"total_display":"800.00","total_whole":"800","shares_owned_after":11359857.0,"shares_owned_after_display":"11,359,857","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-04","filed_date":"2022-10-12","scope":"insider"},{"id":6107036,"accession":"0001209191-22-053433","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-053433","line_url":"/filing/0001209191-22-053433#line-3","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517691","owner_name":"Niihara Yutaka","owner_display_name":"Niihara Yutaka","owner_url":"/insider/0001517691","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.2,"price_display":"0.20","price_state":"stated","total_value":2000.0,"total_display":"2,000.00","total_whole":"2,000","shares_owned_after":11354857.0,"shares_owned_after_display":"11,354,857","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-03","filed_date":"2022-10-12","scope":"insider"},{"id":6107033,"accession":"0001209191-22-053433","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-053433","line_url":"/filing/0001209191-22-053433#line-2","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517691","owner_name":"Niihara Yutaka","owner_display_name":"Niihara Yutaka","owner_url":"/insider/0001517691","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.2,"price_display":"0.20","price_state":"stated","total_value":1000.0,"total_display":"1,000.00","total_whole":"1,000","shares_owned_after":11344857.0,"shares_owned_after_display":"11,344,857","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-27","filed_date":"2022-10-12","scope":"insider"},{"id":6107029,"accession":"0001209191-22-053433","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-053433","line_url":"/filing/0001209191-22-053433#line-1","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517691","owner_name":"Niihara Yutaka","owner_display_name":"Niihara Yutaka","owner_url":"/insider/0001517691","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000.0,"shares_display":"6,000","price_per_share":0.2,"price_display":"0.20","price_state":"stated","total_value":1200.0,"total_display":"1,200.00","total_whole":"1,200","shares_owned_after":11339857.0,"shares_owned_after_display":"11,339,857","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-26","filed_date":"2022-10-12","scope":"insider"},{"id":6752600,"accession":"0001209191-22-033730","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-033730","line_url":"/filing/0001209191-22-033730#line-2","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517691","owner_name":"Niihara Yutaka","owner_display_name":"Niihara Yutaka","owner_url":"/insider/0001517691","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":0.5,"price_display":"0.50","price_state":"stated","total_value":1000.0,"total_display":"1,000.00","total_whole":"1,000","shares_owned_after":11333857.0,"shares_owned_after_display":"11,333,857","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-23","filed_date":"2022-06-02","scope":"insider"},{"id":6752597,"accession":"0001209191-22-033730","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-033730","line_url":"/filing/0001209191-22-033730#line-1","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517691","owner_name":"Niihara Yutaka","owner_display_name":"Niihara Yutaka","owner_url":"/insider/0001517691","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.49,"price_display":"0.49","price_state":"stated","total_value":2450.0,"total_display":"2,450.00","total_whole":"2,450","shares_owned_after":11331857.0,"shares_owned_after_display":"11,331,857","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-20","filed_date":"2022-06-02","scope":"insider"},{"id":6752296,"accession":"0001209191-22-030451","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-030451","line_url":"/filing/0001209191-22-030451#line-3","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517691","owner_name":"Niihara Yutaka","owner_display_name":"Niihara Yutaka","owner_url":"/insider/0001517691","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7351.0,"shares_display":"7,351","price_per_share":0.35,"price_display":"0.35","price_state":"stated","total_value":2572.85,"total_display":"2,572.85","total_whole":"2,573","shares_owned_after":11326857.0,"shares_owned_after_display":"11,326,857","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-18","filed_date":"2022-05-19","scope":"insider"},{"id":6752293,"accession":"0001209191-22-030451","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-030451","line_url":"/filing/0001209191-22-030451#line-2","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517691","owner_name":"Niihara Yutaka","owner_display_name":"Niihara Yutaka","owner_url":"/insider/0001517691","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.34,"price_display":"0.34","price_state":"stated","total_value":3400.0,"total_display":"3,400.00","total_whole":"3,400","shares_owned_after":11319506.0,"shares_owned_after_display":"11,319,506","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-13","filed_date":"2022-05-19","scope":"insider"},{"id":6752289,"accession":"0001209191-22-030451","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-030451","line_url":"/filing/0001209191-22-030451#line-1","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517691","owner_name":"Niihara Yutaka","owner_display_name":"Niihara Yutaka","owner_url":"/insider/0001517691","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000.0,"shares_display":"6,000","price_per_share":0.6,"price_display":"0.60","price_state":"stated","total_value":3600.0,"total_display":"3,600.00","total_whole":"3,600","shares_owned_after":11309506.0,"shares_owned_after_display":"11,309,506","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-09","filed_date":"2022-05-19","scope":"insider"},{"id":6481638,"accession":"0001209191-22-014998","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-014998","line_url":"/filing/0001209191-22-014998#line-1","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517691","owner_name":"Niihara Yutaka","owner_display_name":"Niihara Yutaka","owner_url":"/insider/0001517691","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":53800.0,"shares_display":"53,800","price_per_share":1.49,"price_display":"1.49","price_state":"stated","total_value":80162.0,"total_display":"80,162.00","total_whole":"80,162","shares_owned_after":11303506.0,"shares_owned_after_display":"11,303,506","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-28","filed_date":"2022-03-02","scope":"insider"},{"id":6272480,"accession":"0001209191-22-013475","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-013475","line_url":"/filing/0001209191-22-013475#line-2","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517691","owner_name":"Niihara Yutaka","owner_display_name":"Niihara Yutaka","owner_url":"/insider/0001517691","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5500.0,"shares_display":"5,500","price_per_share":1.41,"price_display":"1.41","price_state":"stated","total_value":7755.0,"total_display":"7,755.00","total_whole":"7,755","shares_owned_after":11249706.0,"shares_owned_after_display":"11,249,706","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-25","filed_date":"2022-02-28","scope":"insider"},{"id":6272478,"accession":"0001209191-22-013475","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-013475","line_url":"/filing/0001209191-22-013475#line-1","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517691","owner_name":"Niihara Yutaka","owner_display_name":"Niihara Yutaka","owner_url":"/insider/0001517691","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11000.0,"shares_display":"11,000","price_per_share":1.43,"price_display":"1.43","price_state":"stated","total_value":15730.0,"total_display":"15,730.00","total_whole":"15,730","shares_owned_after":11244206.0,"shares_owned_after_display":"11,244,206","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-24","filed_date":"2022-02-28","scope":"insider"},{"id":6203994,"accession":"0001209191-22-012064","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-012064","line_url":"/filing/0001209191-22-012064#line-2","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517691","owner_name":"Niihara Yutaka","owner_display_name":"Niihara Yutaka","owner_url":"/insider/0001517691","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":17800.0,"shares_display":"17,800","price_per_share":1.44,"price_display":"1.44","price_state":"stated","total_value":25632.0,"total_display":"25,632.00","total_whole":"25,632","shares_owned_after":11233206.0,"shares_owned_after_display":"11,233,206","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-22","filed_date":"2022-02-23","scope":"insider"},{"id":6203988,"accession":"0001209191-22-012064","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-012064","line_url":"/filing/0001209191-22-012064#line-1","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517691","owner_name":"Niihara Yutaka","owner_display_name":"Niihara Yutaka","owner_url":"/insider/0001517691","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1500.0,"shares_display":"1,500","price_per_share":1.43,"price_display":"1.43","price_state":"stated","total_value":2145.0,"total_display":"2,145.00","total_whole":"2,145","shares_owned_after":11215406.0,"shares_owned_after_display":"11,215,406","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-18","filed_date":"2022-02-23","scope":"insider"},{"id":6272379,"accession":"0001209191-22-011119","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-011119","line_url":"/filing/0001209191-22-011119#line-2","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517691","owner_name":"Niihara Yutaka","owner_display_name":"Niihara Yutaka","owner_url":"/insider/0001517691","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6500.0,"shares_display":"6,500","price_per_share":1.43,"price_display":"1.43","price_state":"stated","total_value":9295.0,"total_display":"9,295.00","total_whole":"9,295","shares_owned_after":11213906.0,"shares_owned_after_display":"11,213,906","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-17","filed_date":"2022-02-18","scope":"insider"},{"id":6272377,"accession":"0001209191-22-011119","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-011119","line_url":"/filing/0001209191-22-011119#line-1","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517691","owner_name":"Niihara Yutaka","owner_display_name":"Niihara Yutaka","owner_url":"/insider/0001517691","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":1.47,"price_display":"1.47","price_state":"stated","total_value":1470.0,"total_display":"1,470.00","total_whole":"1,470","shares_owned_after":11207406.0,"shares_owned_after_display":"11,207,406","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-16","filed_date":"2022-02-18","scope":"insider"},{"id":6777438,"accession":"0001209191-22-010142","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-010142","line_url":"/filing/0001209191-22-010142#line-2","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517691","owner_name":"Niihara Yutaka","owner_display_name":"Niihara Yutaka","owner_url":"/insider/0001517691","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000.0,"shares_display":"6,000","price_per_share":1.45,"price_display":"1.45","price_state":"stated","total_value":8700.0,"total_display":"8,700.00","total_whole":"8,700","shares_owned_after":11206406.0,"shares_owned_after_display":"11,206,406","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-15","filed_date":"2022-02-16","scope":"insider"},{"id":6777434,"accession":"0001209191-22-010142","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-010142","line_url":"/filing/0001209191-22-010142#line-1","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517691","owner_name":"Niihara Yutaka","owner_display_name":"Niihara Yutaka","owner_url":"/insider/0001517691","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000.0,"shares_display":"6,000","price_per_share":1.45,"price_display":"1.45","price_state":"stated","total_value":8700.0,"total_display":"8,700.00","total_whole":"8,700","shares_owned_after":11200406.0,"shares_owned_after_display":"11,200,406","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-14","filed_date":"2022-02-16","scope":"insider"},{"id":6722634,"accession":"0001209191-22-008917","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-008917","line_url":"/filing/0001209191-22-008917#line-3","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517691","owner_name":"Niihara Yutaka","owner_display_name":"Niihara Yutaka","owner_url":"/insider/0001517691","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":1.49,"price_display":"1.49","price_state":"stated","total_value":5960.0,"total_display":"5,960.00","total_whole":"5,960","shares_owned_after":11194406.0,"shares_owned_after_display":"11,194,406","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-11","filed_date":"2022-02-11","scope":"insider"},{"id":6722632,"accession":"0001209191-22-008917","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-008917","line_url":"/filing/0001209191-22-008917#line-2","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517691","owner_name":"Niihara Yutaka","owner_display_name":"Niihara Yutaka","owner_url":"/insider/0001517691","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":1.45,"price_display":"1.45","price_state":"stated","total_value":4350.0,"total_display":"4,350.00","total_whole":"4,350","shares_owned_after":11190406.0,"shares_owned_after_display":"11,190,406","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-10","filed_date":"2022-02-11","scope":"insider"},{"id":6722629,"accession":"0001209191-22-008917","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-008917","line_url":"/filing/0001209191-22-008917#line-1","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517691","owner_name":"Niihara Yutaka","owner_display_name":"Niihara Yutaka","owner_url":"/insider/0001517691","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":23500.0,"shares_display":"23,500","price_per_share":1.45,"price_display":"1.45","price_state":"stated","total_value":34075.0,"total_display":"34,075.00","total_whole":"34,075","shares_owned_after":11187406.0,"shares_owned_after_display":"11,187,406","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-09","filed_date":"2022-02-11","scope":"insider"},{"id":6447158,"accession":"0001209191-22-007990","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-007990","line_url":"/filing/0001209191-22-007990#line-2","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517691","owner_name":"Niihara Yutaka","owner_display_name":"Niihara Yutaka","owner_url":"/insider/0001517691","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3250.0,"shares_display":"3,250","price_per_share":1.49,"price_display":"1.49","price_state":"stated","total_value":4842.5,"total_display":"4,842.50","total_whole":"4,843","shares_owned_after":11163906.0,"shares_owned_after_display":"11,163,906","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-08","filed_date":"2022-02-09","scope":"insider"},{"id":6447154,"accession":"0001209191-22-007990","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-007990","line_url":"/filing/0001209191-22-007990#line-1","is_derivative":false,"issuer_cik":"0000822370","issuer_name":"Emmaus Life Sciences, Inc.","issuer_ticker":"EMMA","issuer_name_source":null,"issuer_url":"/issuer/0000822370","owner_cik":"0001517691","owner_name":"Niihara Yutaka","owner_display_name":"Niihara Yutaka","owner_url":"/insider/0001517691","role":"Director, Officer (Chairman and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5250.0,"shares_display":"5,250","price_per_share":1.47,"price_display":"1.47","price_state":"stated","total_value":7717.5,"total_display":"7,717.50","total_whole":"7,718","shares_owned_after":11160656.0,"shares_owned_after_display":"11,160,656","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-07","filed_date":"2022-02-09","scope":"insider"}],"collapsed":true,"next_cursor":"2022-02-07|6447154","ledger_fault":false,"count":{"value":374,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":373,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":374},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000822370","name":"Emmaus Life Sciences, Inc.","url":"/issuer/0000822370","role":"Director, Officer (Chairman and CEO), Ten percent owner","n_filings":128,"first_seen":"2019-08-21","last_seen":"2022-12-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001420031","name":"EMMAUS LIFE SCIENCES, INC.","url":"/issuer/0001420031","role":"Director, Officer (Chairman and CEO), Ten percent owner","n_filings":4,"first_seen":"2013-06-04","last_seen":"2019-05-31"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001517691","retrieved_at":"2026-08-25T12:09:08+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}